Using sgRNA competition assays we confirmed that silencing the 440 kb and 1.8 Mb enhancers affected the viability of mesothelioma and uveal melanoma cells, respectively, with a corresponding lineage-specific impact on MYC expression (Fig. S7B, C). This evidence concerns the gene MYC and uveal melanoma.